MERIT MEDICAL SYSTEMS INC Quarterly Amortization of Intangible Assets in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Merit Medical Systems Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2012 to Q3 2024.
  • Merit Medical Systems Inc Amortization of Intangible Assets for the quarter ending September 30, 2024 was $16.9M, a 9.74% increase year-over-year.
  • Merit Medical Systems Inc Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $61.3M, a 15.4% increase year-over-year.
  • Merit Medical Systems Inc annual Amortization of Intangible Assets for 2023 was $56.1M, a 15.9% increase from 2022.
  • Merit Medical Systems Inc annual Amortization of Intangible Assets for 2022 was $48.4M, a 2.42% decline from 2021.
  • Merit Medical Systems Inc annual Amortization of Intangible Assets for 2021 was $49.6M, a 15.4% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $61.3M $16.9M +$1.5M +9.74% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $59.8M $14.8M +$1.4M +10.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $58.4M $14.6M +$2.3M +18.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $56.1M $15M +$3M +25% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $53.1M $15.4M +$3.3M +27.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $49.8M $13.4M +$1.3M +10.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $48.5M $12.3M +$100K +0.82% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $48.4M $12M -$300K -2.44% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $48.7M $12.1M -$300K -2.42% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $49M $12.1M -$300K -2.42% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $49.3M $12.2M -$300K -2.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $49.6M $12.3M -$2.1M -14.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $51.7M $12.4M -$2M -13.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $53.7M $12.4M -$2.4M -16.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $56.1M $12.5M -$2.5M -16.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $58.6M $14.4M -$1.1M -7.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $59.7M $14.4M -$1.1M -7.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $60.8M $14.8M -$100K -0.67% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $60.9M $15M +$200K +1.35% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $60.7M $15.5M +$3.7M +31.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $57M $15.5M +$5M +47.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $52M $14.9M +$4.5M +43.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $47.5M $14.8M +$6.3M +74.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $41.2M $11.8M +$4.4M +59.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $36.8M $10.5M +$3.5M +50% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $33.3M $10.4M +$4.2M +67.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $29.1M $8.5M +$2.3M +37.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $26.8M $7.4M +$1.7M +29.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $25.1M $7M +$1.3M +22.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $23.8M $6.2M +$2.2M +55% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $21.6M $6.2M +$2.3M +59% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $19.3M $5.7M +$1.9M +50% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $17.4M $5.7M +$2M +54.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $15.4M $4M +$300K +8.11% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $15.1M $3.9M +$300K +8.33% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $14.8M $3.8M +$100K +2.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $14.7M $3.7M -$100K -2.63% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $14.8M $3.7M $0 0% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $14.8M $3.6M -$100K -2.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $14.9M $3.7M -$100K -2.63% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $15M $3.8M +$400K +11.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $14.6M $3.7M +$200K +5.71% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $14.4M $3.7M +$200K +5.71% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $14.2M $3.8M +$2M +111% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $12.2M $3.4M +$1.5M +78.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $10.7M $3.5M +$1.6M +84.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $9.1M $3.5M +$1.6M +84.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $7.5M $1.8M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-05
Q3 2012 $1.9M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $1.9M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $1.9M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.